Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK(1)) receptor antagonists

Por Bošnjak, Snežana M., Gralla, Richard J., Schwartzberg, Lee
Publicado no Support Care Cancer (2017)

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting ov...

Por Gralla, R. J., Bosnjak, S. M., Hontsa, A., Balser, C., Rizzi, G., Rossi, G., Borroni, M. E., Jordan, K.
Publicado em 2014